Age-related macular degeneration

Area of Science:

• Ophthalmology
• Public Health
• Gerontology

Background:

• Age-related macular degeneration (AMD) is a growing public health concern, particularly affecting individuals over 55.
• AMD threatens central vision, impacting daily activities like reading, driving, and facial recognition.
• Increasing longevity and aging populations exacerbate the prevalence of AMD.

Purpose of the Study:

• To review current understanding and advancements in age-related macular degeneration (AMD).
• To highlight progress in diagnosing and treating neovascular and atrophic AMD.
• To identify unmet needs in managing early-stage AMD and preventing disease progression.

Main Methods:

• Review of recent literature on retinal imaging biomarkers for AMD progression.
• Analysis of emerging therapeutic strategies for neovascular and atrophic AMD.
• Assessment of current challenges in early AMD intervention and prevention.

Main Results:

• Retinal imaging advances have identified biomarkers predicting progression to late AMD.
• New treatments for neovascular AMD show promise for longer-lasting effects.
• Progress is being made in developing treatments for atrophic AMD.

Conclusions:

• Despite advances, an effective intervention to slow early AMD progression or prevent late AMD is still needed.
• Understanding the underlying mechanistic pathways of AMD is crucial and evolving.
• Continued research is essential to address the public health challenge posed by AMD.